Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SiloxysSystem Gel is a proprietary, patented silicone-based topical drug-delivery system developed by XYON Health for the treatment of androgenetic alopecia. It serves as a controlled-release matrix for compounding active pharmaceutical ingredients such as finasteride, dutasteride, and minoxidil. The gel forms a silicone-based lattice on the scalp that anchors the medication at the hair follicle, facilitating a gradual release over several hours. This localized delivery is designed to maintain high concentrations of the active drug at the target site while significantly reducing systemic absorption—reportedly up to 92% less than oral finasteride—thereby minimizing the risk of systemic side effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SiloxysSystem Gel.